[The use of hydroxyapatite with ultrahigh dispersity in the combined treatment of patients with mandibular fractures].
Altogether 125 patients with mandibular fractures of different localization were treated. Implantation of ultrahigh dispersed hydroxyapatite was included in the treatment schemes, both surgical and conservative, of 65 of these patients. Such implantations were found easy to perform, well tolerated by the patients, and causing no side effects. The incidence of complications in this group was by 6.78% lower than in controls treated by the traditional methods alone and by 7.16% lower than in all patients with mandibular fractures treated over a year. The mean disability period was reduced by 4.8 days when this preparation was used.
Pankratov
A S
AS
Zuev
V P
VP
Alekseeva
A N
AN
D001672:Biocompatible Materials / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D017886:Durapatite / Q000627:therapeutic use*; D005260:Female; D005592:Fracture Fixation / Q000379:methods; D017102:Fracture Healing / Q000187:drug effects; D006801:Humans; D008297:Male; D008337:Mandibular Fractures / Q000503:physiopathology / Q000628:therapy*; D009824:Ointments; D010012:Osteogenesis / Q000187:drug effects; D010316:Particle Size
D001672:Biocompatible Materials; D009824:Ointments; D017886:Durapatite